No, do not increase the melatonin dose from 5 mg
Instead of increasing the dose, the patient should take melatonin 1-3 hours earlier (around 6 PM or 3 hours before desired bedtime) rather than at bedtime, as timing is more critical than dose for melatonin's effectiveness. 1
Why Increasing Dose is Not the Answer
The evidence clearly shows that 5 mg melatonin showed no improvement in sleep outcomes in multiple studies 2. The American Academy of Sleep Medicine guidelines found that even at 5 mg, there was no benefit for sleep latency, total sleep time, or sleep quality 2. This suggests the problem is not insufficient dosing but rather incorrect use.
The Dose-Response Relationship
- Optimal dose peaks at 4 mg/day according to dose-response meta-analysis 1
- Studies testing 0.1 mg, 0.3 mg, and 3 mg showed similar efficacy, with some evidence that lower doses (0.3 mg) may be as effective as higher doses 2
- The most studied and effective dose is 2 mg prolonged-release formulation 2
- Going beyond 4-5 mg provides no additional benefit and may increase side effects like drowsiness and headache 3, 4
What Actually Matters: Timing Over Dose
The critical factor for melatonin efficacy is when you take it, not how much:
- Time between administration and sleep episode is a significant predictor of effectiveness (β = -0.16, p = 0.023) 1
- Optimal timing is 1-3 hours before desired bedtime (around 6 PM for typical sleep schedules), not at bedtime 1, 5
- Melatonin acts primarily as a chronobiotic (circadian rhythm regulator), not a sedative-hypnotic 6
- Taking it at bedtime is a common error that leads to treatment failure 6
Recommended Action Plan
Before changing anything, verify this is actually insomnia and not a circadian rhythm disorder:
- If the patient naturally falls asleep late but sleeps well once asleep = likely delayed sleep phase disorder
- If difficulty both falling and staying asleep with daytime dysfunction = chronic insomnia disorder
For Chronic Insomnia:
- Stop melatonin entirely - The 2020 VA/DoD guidelines found insufficient evidence to support melatonin for chronic insomnia disorder, with only 7-8 minute improvements in sleep parameters that lack clinical significance 7
- Recommend Cognitive Behavioral Therapy for Insomnia (CBT-I) as first-line treatment 7
For Circadian Rhythm Issues (Delayed Sleep Phase):
- Reduce dose to 2-4 mg (preferably prolonged-release formulation)
- Take 3 hours before desired bedtime (e.g., 6 PM for 9 PM bedtime) 1, 5
- Combine with morning bright light exposure to reinforce circadian shift
For Elderly Patients (≥55 years):
- This is the only population with clear evidence of benefit 2
- Use 2 mg prolonged-release formulation
- Timing still matters: 1-2 hours before bedtime 8, 9
Important Caveats
Common pitfalls to avoid:
- Supraphysiological dosing (>5 mg) has become normalized despite lack of evidence 6
- Over-the-counter formulations vary dramatically in actual melatonin content - some contain 83% less or 478% more than labeled 6
- Melatonin is not FDA-approved for any indication, creating ambiguity in proper use 5
- Side effects increase with dose: drowsiness (28.8%), headache (25.1%) are common at 5 mg 4
The patient's lack of response at 5 mg strongly suggests:
- Wrong timing of administration
- Misdiagnosis (treating insomnia when it's actually a circadian disorder, or vice versa)
- Primary insomnia that won't respond to melatonin regardless of dose 7
Bottom line: The evidence shows that if 5 mg isn't working, taking more won't help - but taking it earlier might. 1, 6